BACKGROUND: The anticoagulant treatment of acute deep venous thrombosis (DVT) has
been historically directed toward the prevention of recurrent venous thromboembolism …

Thrombosis of the inferior vena cava (IVC) is an under-recognized entity that is associated
with significant short-and long-term morbidity and mortality. In absence of a congenital …

2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

Background: Approximately one in four patients with acute proximal deep vein thrombosis
(DVT) given anticoagulation and compression therapy develop post-thrombotic syndrome …

The draft document is critically reviewed by the Standards of Practice Committee members
by telephone conference calling or faceto-face meeting. The finalized draft from the …

Inferior vena cava (IVC) thrombosis remains under-recognised as it is often not pursued as a
primary diagnosis. The aetiology of IVC thrombosis can be divided into congenital versus …

BACKGROUND: In selected cases of deep vein thrombosis (DVT), catheter-directed
thrombolysis (CDT) may be superior to conventional treatment with anticoagulation alone …

PURPOSE: Catheter-directed thrombolysis (CDT) for proximal deep vein thrombosis (DVT)
effectively enhances clot removal and recently has been shown to reduce the development …

Objectives The purpose of this study was to evaluate the necessity of and recommend
indications for inferior vena cava (IVC) filter implantation during percutaneous endovenous …

Deep vein thromboses (DVTs) cause significant morbidity and mortality in the general
population. Oral anticoagulation therapy may reduce thrombus propagation but does not …